These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36951214)

  • 1. TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.
    van Hummel A; Sabale M; Przybyla M; van der Hoven J; Chan G; Feiten AF; Chung RS; Ittner LM; Ke YD
    Neuropathol Appl Neurobiol; 2023 Apr; 49(2):e12902. PubMed ID: 36951214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 is a ubiquitylation substrate of the SCF
    Rayner SL; Yang S; Farrawell NE; Jagaraj CJ; Cheng F; Davidson JM; Luu L; Redondo AG; Rábano A; Borrego-Hernández D; Atkin JD; Morsch M; Blair IP; Yerbury JJ; Chung R; Lee A
    Neurobiol Dis; 2022 Jun; 167():105673. PubMed ID: 35231559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.
    Rayner SL; Cheng F; Hogan AL; Grima N; Yang S; Ke YD; Au CG; Morsch M; De Luca A; Davidson JM; Molloy MP; Shi B; Ittner LM; Blair I; Chung RS; Lee A
    Hum Mol Genet; 2021 May; 30(11):971-984. PubMed ID: 33729478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy.
    Lee A; Rayner SL; Gwee SSL; De Luca A; Shahheydari H; Sundaramoorthy V; Ragagnin A; Morsch M; Radford R; Galper J; Freckleton S; Shi B; Walker AK; Don EK; Cole NJ; Yang S; Williams KL; Yerbury JJ; Blair IP; Atkin JD; Molloy MP; Chung RS
    Cell Mol Life Sci; 2018 Jan; 75(2):335-354. PubMed ID: 28852778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis.
    Farrawell NE; Bax M; McAlary L; McKenna J; Maksour S; Do-Ha D; Rayner SL; Blair IP; Chung RS; Yerbury JJ; Ooi L; Saunders DN
    Hum Mol Genet; 2023 Jul; 32(14):2386-2398. PubMed ID: 37220877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype.
    Hogan AL; Don EK; Rayner SL; Lee A; Laird AS; Watchon M; Winnick C; Tarr IS; Morsch M; Fifita JA; Gwee SSL; Formella I; Hortle E; Yuan KC; Molloy MP; Williams KL; Nicholson GA; Chung RS; Blair IP; Cole NJ
    Hum Mol Genet; 2017 Jul; 26(14):2616-2626. PubMed ID: 28444311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 Ubiquitin Ligase SCF Cyclin F Promotes Sequestosome-1/p62 Insolubility and Foci Formation and is Dysregulated in ALS and FTD Pathogenesis.
    Davidson JM; Wu SSL; Rayner SL; Cheng F; Duncan K; Russo C; Newbery M; Ding K; Scherer NM; Balez R; García-Redondo A; Rábano A; Rosa-Fernandes L; Ooi L; Williams KL; Morsch M; Blair IP; Di Ieva A; Yang S; Chung RS; Lee A
    Mol Neurobiol; 2023 Sep; 60(9):5034-5054. PubMed ID: 37243816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.
    Williams KL; Topp S; Yang S; Smith B; Fifita JA; Warraich ST; Zhang KY; Farrawell N; Vance C; Hu X; Chesi A; Leblond CS; Lee A; Rayner SL; Sundaramoorthy V; Dobson-Stone C; Molloy MP; van Blitterswijk M; Dickson DW; Petersen RC; Graff-Radford NR; Boeve BF; Murray ME; Pottier C; Don E; Winnick C; McCann EP; Hogan A; Daoud H; Levert A; Dion PA; Mitsui J; Ishiura H; Takahashi Y; Goto J; Kost J; Gellera C; Gkazi AS; Miller J; Stockton J; Brooks WS; Boundy K; Polak M; Muñoz-Blanco JL; Esteban-Pérez J; Rábano A; Hardiman O; Morrison KE; Ticozzi N; Silani V; de Belleroche J; Glass JD; Kwok JB; Guillemin GJ; Chung RS; Tsuji S; Brown RH; García-Redondo A; Rademakers R; Landers JE; Gitler AD; Rouleau GA; Cole NJ; Yerbury JJ; Atkin JD; Shaw CE; Nicholson GA; Blair IP
    Nat Commun; 2016 Apr; 7():11253. PubMed ID: 27080313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
    Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin F, Neurodegeneration, and the Pathogenesis of ALS/FTD.
    Rayner SL; Hogan A; Davidson JM; Cheng F; Luu L; Morsch M; Blair I; Chung R; Lee A
    Neuroscientist; 2024 Apr; 30(2):214-228. PubMed ID: 36062310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of CCNF gene is rare in patients with amyotrophic lateral sclerosis and frontotemporal dementia from Mainland China.
    Pan C; Jiao B; Xiao T; Hou L; Zhang W; Liu X; Xu J; Tang B; Shen L
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):265-268. PubMed ID: 28281833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casein kinase II phosphorylation of cyclin F at serine 621 regulates the Lys48-ubiquitylation E3 ligase activity of the SCF
    Lee A; Rayner SL; De Luca A; Gwee SSL; Morsch M; Sundaramoorthy V; Shahheydari H; Ragagnin A; Shi B; Yang S; Williams KL; Don EK; Walker AK; Zhang KY; Yerbury JJ; Cole NJ; Atkin JD; Blair IP; Molloy MP; Chung RS
    Open Biol; 2017 Oct; 7(10):. PubMed ID: 29021214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice.
    McCann EP; Fifita JA; Grima N; Galper J; Mehta P; Freckleton SE; Zhang KY; Henden L; Hogan AL; Chan Moi Fat S; Wu SS; Jagaraj CJ; Berning BA; Williams KL; Twine NA; Bauer D; Piguet O; Hodges J; Kwok JBJ; Halliday GM; Kiernan MC; Atkin J; Rowe DB; Nicholson GA; Walker AK; Blair IP; Yang S
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):162-171. PubMed ID: 31690696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
    Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
    Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations.
    Le NT; Chang L; Kovlyagina I; Georgiou P; Safren N; Braunstein KE; Kvarta MD; Van Dyke AM; LeGates TA; Philips T; Morrison BM; Thompson SM; Puche AC; Gould TD; Rothstein JD; Wong PC; Monteiro MJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(47):E7580-E7589. PubMed ID: 27834214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural Variant Frontotemporal Dementia due to
    You FL; Xia GF; Cai J
    Curr Alzheimer Res; 2023; 20(5):371-378. PubMed ID: 37872794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
    Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
    Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALS/FTD-associated mutation in cyclin F inhibits ER-Golgi trafficking, inducing ER stress, ERAD and Golgi fragmentation.
    Ragagnin AMG; Sundaramoorthy V; Farzana F; Gautam S; Saravanabavan S; Takalloo Z; Mehta P; Do-Ha D; Parakh S; Shadfar S; Hunter J; Vidal M; Jagaraj CJ; Brocardo M; Konopka A; Yang S; Rayner SL; Williams KL; Blair IP; Chung RS; Lee A; Ooi L; Atkin JD
    Sci Rep; 2023 Nov; 13(1):20467. PubMed ID: 37993492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features.
    Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM
    Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.